Eiry Roberts is Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX). They have made 13 open-market trades across 1 company since 2019, most recently 2026-05-22.
CIK 0001727606
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NBIX | SELL · 10b5-1 | 2025-02-13 | 2025-02-14 | $116.61 | $459K | +2.2% | -3.1% | +4.6% |
| NBIX | SELL · 10b5-1 | 2025-02-10 | 2025-02-12 | $118.22 | $232K | -1.2% | -5.6% | -0.4% |
| NBIX | SELL · 10b5-1 | 2025-01-31 | 2025-02-04 | $152.80 | $445K | -24.2% | -25.7% | -27.6% |
| NBIX | SELL · 10b5-1 | 2024-02-13 | 2024-02-15 | $132.96 | $296K | +0.4% | +3.9% | +5.9% |
| NBIX | SELL · 10b5-1 | 2024-02-06 | 2024-02-08 | $138.49 | $582K | -3.0% | +2.9% | +3.2% |
| NBIX | SELL · 10b5-1 | 2024-01-31 | 2024-02-02 | $140.79 | $410K | -6.7% | -5.7% | -1.0% |
| NBIX | SELL · 10b5-1 | 2023-12-22 | 2023-12-27 | $126.74 | $1.3M | +0.8% | +7.2% | +6.4% |
| NBIX | SELL · 10b5-1 | 2023-12-12 | 2023-12-14 | $120.30 | $3.4M | +9.5% | +9.4% | +16.9% |
| NBIX | SELL · 10b5-1 | 2023-12-07 | 2023-12-11 | $120.37 | $18.7M | +1.8% | +11.2% | +16.5% |
| NBIX | SELL · 10b5-1 | 2023-12-06 | 2023-12-08 | $120.03 | $2.0M | +2.6% | +14.3% | +15.5% |
| NBIX | SELL · 10b5-1 | 2023-08-21 | 2023-08-23 | $107.38 | $687K | +2.1% | +5.6% | +1.8% |
| NBIX | SELL · 10b5-1 | 2023-04-24 | 2023-04-26 | $103.48 | $1.5M | -4.3% | -10.9% | -1.3% |
| NBIX | SELL | 2023-02-06 | 2023-02-08 | $102.74 | $3.4M | -2.5% | -8.5% | -7.2% |
| NBIX | SELL | 2023-01-31 | 2023-02-02 | $109.99 | $321K | -5.8% | -7.8% | -9.8% |
| NBIX | SELL | 2022-02-07 | 2022-02-09 | $80.45 | $599K | +10.7% | +12.7% | +3.8% |
| NBIX | SELL | 2022-01-10 | 2022-01-12 | $74.50 | $196K | -1.4% | +11.0% | +27.2% |
| NBIX | SELL | 2021-02-08 | 2021-02-09 | $116.78 | $552K | -4.3% | -18.5% | -21.3% |
| NBIX | SELL | 2021-01-08 | 2021-01-12 | $111.06 | $585K | +5.9% | +2.3% | -17.7% |
| NBIX | SELL | 2020-11-12 | 2020-11-16 | $90.74 | $410K | +3.1% | +6.5% | +21.3% |
| NBIX | SELL | 2020-08-05 | 2020-08-07 | $118.84 | $536K | -1.6% | -4.5% | -12.7% |
| NBIX | SELL | 2020-06-23 | 2020-06-25 | $130.00 | $650K | +0.9% | -2.3% | -22.9% |
| NBIX | SELL | 2020-04-24 | 2020-04-28 | $99.47 | $385K | +9.0% | +19.8% | +25.5% |
| NBIX | SELL | 2020-02-07 | 2020-02-11 | $103.31 | $335K | -9.5% | -24.4% | +6.0% |
| NBIX | SELL | 2020-01-08 | 2020-01-10 | $111.11 | $585K | -10.1% | -6.8% | -15.0% |
| NBIX | SELL | 2019-01-08 | 2019-01-10 | $84.09 | $312K | +6.0% | +0.5% | +8.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.